The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Hanmi Pharm Co Ltd
KRX:128940
|
KR |
|
C
|
Cablevision Holding SA
OTC:CVHSY
|
AR |
|
S
|
Southern Co
LSE:0L8A
|
US |
|
Experian PLC
LSE:EXPN
|
IE |
|
Universal Ibogaine Inc
XTSX:IBO
|
CA |
|
Novozymes A/S
OTC:NVZMY
|
DK |
|
T
|
Trane Technologies PLC
XMUN:2IS
|
IE |
|
P
|
Power Corporation of Canada
F:PCR
|
CA |
|
R
|
REN Redes Energeticas Nacionais SGPS SA
SWB:RN4
|
PT |
|
B
|
BlackRock Inc
F:UU2
|
US |
|
P
|
Paychex Inc
DUS:PCX
|
US |
|
N
|
Netcall PLC
SWB:NEW
|
UK |
|
Bell Financial Group Ltd
ASX:BFG
|
AU |
|
AMC Entertainment Holdings Inc
F:AH91
|
US |
|
J
|
Jiangxi Copper Co Ltd
SWB:JIX
|
CN |
|
Allianz SE
SIX:ALV
|
DE |
|
Old Second Bancorp Inc
F:OSB
|
US |
Hanmi Pharm Co Ltd (128940)’s 12-month stock price forecast through October 2027 has a consensus target of ₩663 000, implying 31% upside. The forecast is based on price targets from 19 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for
Hanmi Pharm Co Ltd is 663 000 KRW with a low forecast of 474 700 KRW and a high forecast of 850 500 KRW.
Over the last 13 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 3 years is 8%.
Over the last 13 years, the compound annual growth rate for Gross Profit has been 6%. The projected CAGR for the next 3 years is 8%.
Over the last 13 years, the compound annual growth rate for Operating Income has been 14%. The projected CAGR for the next 3 years is 8%.
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 16%. The projected CAGR for the next 3 years is 14%.
Over the last 13 years, the compound annual growth rate for Net Income has been 17%. The projected CAGR for the next 3 years is 15%.
AI-generated answers can contain mistakes, outdated facts, or incomplete information. Always verify important details before making decisions.
The AI Assistant is designed for research and education. It does not provide personalized investment, legal, or tax advice.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more